X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (71) 71
index medicus (46) 46
male (46) 46
pharmacology & pharmacy (45) 45
female (35) 35
middle aged (27) 27
adult (25) 25
oxidative stress (24) 24
animals (23) 23
in vitro techniques (21) 21
rats (21) 21
isoprostanes (20) 20
dose-response relationship, drug (19) 19
aged (16) 16
thromboxane a (16) 16
atherosclerosis (15) 15
hypertension (15) 15
lipid peroxidation (14) 14
cardiac & cardiovascular systems (13) 13
inflammation (13) 13
vasoconstriction - drug effects (13) 13
vasoconstrictor agents - pharmacology (13) 13
dinoprost - analogs & derivatives (12) 12
intermittent hypoxia (11) 11
leukotrienes (11) 11
mass spectrometry (11) 11
therapeutic drug monitoring (10) 10
vasoconstriction (10) 10
5-lipoxygenase (9) 9
cysteinyl leukotrienes (9) 9
f2-alpha (9) 9
health aspects (9) 9
life sciences (9) 9
muscle, smooth, vascular - drug effects (9) 9
oxidant stress (9) 9
pharmacokinetics (9) 9
receptors (9) 9
15-hydroxy-11 alpha,9 alpha-prosta-5,13-dienoic acid - pharmacology (8) 8
blood-pressure (8) 8
isoprostane (8) 8
mammary arteries - drug effects (8) 8
obesity (8) 8
risk factors (8) 8
saphenous vein (8) 8
angiotensin ii (7) 7
biochemistry & molecular biology (7) 7
cell biology (7) 7
chemistry, analytical (7) 7
disease (7) 7
expression (7) 7
f-2-isoprostanes (7) 7
f2-isoprostanes (7) 7
in-vivo (7) 7
internal medicine (7) 7
liquid chromatography (7) 7
pharmacology (7) 7
physiology (7) 7
receptor (7) 7
vascular reactivity (7) 7
8-epi-prostaglandin f2-alpha (6) 6
angiotensin ii - pharmacology (6) 6
antifungal agents (6) 6
arachidonic-acid (6) 6
case-control studies (6) 6
dinoprost - pharmacology (6) 6
drug interactions (6) 6
drug monitoring (6) 6
endocrinology & metabolism (6) 6
endothelium (6) 6
genotype (6) 6
haptoglobin (6) 6
internal mammary artery (6) 6
leukotriene e4 - urine (6) 6
lipid-peroxidation (6) 6
lipoxygenase inhibitors - pharmacology (6) 6
mammary artery (6) 6
microbiology (6) 6
muscle contraction - drug effects (6) 6
peripheral vascular disease (6) 6
positive airway pressure (6) 6
potassium chloride - pharmacology (6) 6
rat aorta (6) 6
rats, wistar (6) 6
receptors, thromboxane - antagonists & inhibitors (6) 6
research (6) 6
saphenous vein - drug effects (6) 6
sleep apnea syndromes (6) 6
smooth-muscle cells (6) 6
tandem mass spectrometry (6) 6
vasoconstriction - physiology (6) 6
5-lipoxygenase-activating protein (5) 5
8-iso-prostaglandin f2-alpha (5) 5
abridged index medicus (5) 5
activation (5) 5
adolescent (5) 5
angiotensin-ii (5) 5
aorta, thoracic - drug effects (5) 5
benzoquinones - pharmacology (5) 5
biochemical research methods (5) 5
biomarkers (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Analytical and Bioanalytical Chemistry, ISSN 1618-2642, 2/2017, Volume 409, Issue 5, pp. 1195 - 1205
Journal Article
British Journal of Clinical Pharmacology, ISSN 0306-5251, 04/2019, Volume 85, Issue 4, pp. 722 - 728
Aims Therapeutic drug monitoring (TDM) of infliximab (IFX) appears to be beneficial for patients with inflammatory bowel disease (IBD). However, the... 
mass spectrometry | infliximab | therapeutic drug monitoring | ANTIBODIES | PHARMACOLOGY & PHARMACY | Care and treatment | Infliximab | Patient monitoring equipment | Gastrointestinal diseases | Medical records | Liquid chromatography | Mass spectrometry | Health aspects | Index Medicus
Journal Article
Journal Article
Thorax, ISSN 0040-6376, 09/2015, Volume 70, Issue 9, pp. 815 - 816
Journal Article
Clinical Pharmacology & Therapeutics, ISSN 0009-9236, 04/2014, Volume 95, Issue 4, pp. 439 - 445
Journal Article
Drug Testing and Analysis, ISSN 1942-7603, 06/2018, Volume 10, Issue 6, pp. 995 - 1000
The use of new psychoactive substances (NPS) has rapidly increased over the last decade. In the last 4 years, producers increasingly appear to be targeting... 
LC–HRMS | ocfentanil | fatality | HLMs | metabolites | CHEMISTRY, ANALYTICAL | IN-VITRO | BIOCHEMICAL RESEARCH METHODS | VALIDATION | PHARMACOLOGY & PHARMACY | LC-HRMS | CHROMATOGRAPHY | FENTANYL | Metabolites | Mass spectrometry | Analysis
Journal Article
Pharmacology and Therapeutics, ISSN 0163-7258, 06/2018, Volume 186, pp. 45 - 59
Journal Article
British Journal of Clinical Pharmacology, ISSN 0306-5251, 08/2008, Volume 66, Issue 2, pp. 179 - 195
Highly active antiretroviral therapy is recommended for HIV-infected pregnant women to prevent mother-to-child transmission. The specific physiological... 
pharmacokinetics | protease inhibitors | HIV mother-to-child transmission | antiretrovirals | therapeutic drug monitoring | pregnancy | HIV mother‐to‐child transmission | Pregnancy | Therapeutic drug monitoring | Antiretrovirals | Protease inhibitors | Pharmacokinetics | VIRAL LOAD | CLINICAL-PHARMACOLOGY | LOW-BIRTH-WEIGHT | VIROLOGICAL RESPONSE | P-GLYCOPROTEIN | NONNUCLEOSIDE REVERSE-TRANSCRIPTASE | PLASMA-CONCENTRATIONS | LOW-DOSE RITONAVIR | PHARMACOLOGY & PHARMACY | CHILD HIV TRANSMISSION | HIV Infections - prevention & control | Humans | Treatment Outcome | Drug Monitoring - methods | HIV Protease Inhibitors - therapeutic use | Viral Load | Antiretroviral Therapy, Highly Active | Reverse Transcriptase Inhibitors - pharmacokinetics | HIV Protease Inhibitors - pharmacokinetics | Pregnancy Complications, Infectious - drug therapy | Pregnancy Complications, Infectious - prevention & control | Female | HIV Infections - drug therapy | HIV Infections - transmission | Reverse Transcriptase Inhibitors - therapeutic use | Infectious Disease Transmission, Vertical - prevention & control | Highly active antiretroviral therapy | Disease transmission | Proteases | Pregnant women | HIV (Viruses) | Health aspects | HIV Infections | Pregnancy Complications, Infectious | Infectious Disease Transmission, Vertical | HIV Protease Inhibitors | Life Sciences | Reverse Transcriptase Inhibitors | Drug Monitoring | Pharmaceutical sciences | Review
Journal Article